Development code · Small Molecule
NBI-1117570
NBI-1117570 is a development code for NBI-1117570, developed by Neurocrine Biosciences, Inc..
- Status
- Phase 2 for Schizophrenia
- Mechanism
- M4 Agonist
- Developer
- Neurocrine Biosciences, Inc.
Programs
- NBI-1117570 for SchizophreniaPhase 2Recruiting
Also known as
- NBI-570
- NBI-'570